Maode Wang
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Genetics top 2%
- Glioma Diagnosis and Treatment
Papers in ⓘ
- Genetics 30
- Glioma Diagnosis and Treatment 30
-
- Cancer Genomics and Diagnostics 6
- Cancer-related molecular mechanisms research 6
- Cancer, Hypoxia, and Metabolism 6
- Co-authors
- Ping Mao (9 shared papers)Wanfu Xie (20 shared papers)L.T. Smith (2 shared papers)Xiaobin Bai (14 shared papers)Ichiro Nakano (2 shared papers)Sung-Hak Kim (2 shared papers)Robert W. Sobol (1 shared paper)Jia Wang (12 shared papers)
- Journals
- Oncotarget (4 papers)Translational Oncology (4 papers)Journal of Neuro-Oncology (3 papers)Biomedicine & Pharmacotherapy (3 papers)Frontiers in Oncology (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Maode Wang
69 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Cancer Research 768
- Genetics 461
- Molecular Biology 1.2k
- Oncology 479
- Immunology 175
Countries citing papers authored by Maode Wang
This map shows the geographic impact of Maode Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maode Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maode Wang more than expected).
Fields of papers citing papers by Maode Wang
This network shows the impact of papers produced by Maode Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maode Wang. The network helps show where Maode Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Maode Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3 Hit paper breakdown → | 2013 | 501 |
| 2 | 2019 | 114 | |
| 3 | 2019 | 105 | |
| 4 | 2015 | 95 | |
| 5 | Schizandrin A protects against cerebral ischemia-reperfusion injury by suppressing inflammation and oxidative stress and regulating the AMPK/Nrf2 pathway regulation. | 2019 | 74 |
| 6 | 2016 | 58 | |
| 7 | 2015 | 57 | |
| 8 | 2020 | 50 | |
| 9 | 2014 | 39 | |
| 10 | 2020 | 33 | |
| 11 | 2017 | 33 | |
| 12 | 2016 | 31 | |
| 13 | 2013 | 30 | |
| 14 | 2017 | 28 | |
| 15 | 2018 | 27 | |
| 16 | 2020 | 27 | |
| 17 | 2021 | 24 | |
| 18 | 2019 | 24 | |
| 19 | 2015 | 24 | |
| 20 | 2005 | 23 |
About Maode Wang
Maode Wang is a scholar working on Genetics, Cancer Research, Cell Biology, Oncology and Molecular Biology, having authored 71 papers that have together received 1.9k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (30 papers), Microtubule and mitosis dynamics (8 papers), Cancer Genomics and Diagnostics (6 papers), Epigenetics and DNA Methylation (6 papers), Ferroptosis and cancer prognosis (6 papers), Cancer-related molecular mechanisms research (6 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Cancer Research (768 citations), Genetics (461 citations), Molecular Biology (1.2k citations), Oncology (479 citations) and Immunology (175 citations). Maode Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Ping Mao, Wanfu Xie, L.T. Smith, Xiaobin Bai, Ichiro Nakano, Sung-Hak Kim, Robert W. Sobol, Jia Wang, Panayiotis V. Benos and Soumya Luthra. Their work appears in journals such as Oncotarget, Translational Oncology, Journal of Neuro-Oncology, Biomedicine & Pharmacotherapy and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.